试析第三方平台药品经营权利与责任的法律规制  

Analysis on the Legal Regulation of the Rights and Responsibilities of Drug Management on the Thirdparty Platform

作　　者：冀玮 JI Wei(School of Government,University of International Business and Economics)

机构地区：[1]对外经济贸易大学政府管理学院

出　　处：《中国食品药品监管》2023年第2期64-69,共6页China Food & Drug Administration Magazine

摘　　要：第三方平台药品网络销售既是有利于人民群众用药疗病的善策,也是未来的发展趋势。本文从法律法规规制的根本目的出发,对第三方平台“不得直接参与药品网络销售活动”“对于未通过处方审核的,不得直接展示处方药的包装、标签、说明书等信息”“国家实行特殊管理以及用药风险较高的药品不得通过网络零售”的强制禁止性规定进行分析,指出其政策性利弊,并提出建议。The network sale of drugs on the third-party platform is not only a good policy for the people to use drugs to treat diseases,but also a development trend in the future.Starting from the fundamental purpose of laws and regulations,this article analyzes the mandatory prohibitive provisions of the third-party platform,such as“not to directly participate in drug online sales activities”,“not to directly display the packaging,labels,package inserts and other information of prescription drugs that have not passed the prescription review”,and“drugs specially managed by the country and drugs with high drug risk shall not be retail through the network”.Also,this article points out the advantages and disadvantages of these policies and makes suggestions.

关 键 词：药品网络销售 信息展示 特殊管理药品 高风险药品 

分 类 号：R95[医药卫生—药学]